AUSTIN, Texas & HONG KONG--(BUSINESS WIRE)--Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, and Mingyuan Medicare Development Company, a leading supplier of biomedical products in China, today announced the signing of a distribution and supply agreement. Under the terms of the agreement, Mingyuan will serve as the exclusive distributor in China and Hong Kong of a series of newborn screening products being developed for the diagnosis of genetic disorders.
